Hypersensitivity reaction to Abiraterone, successful desensitization protocol in prostate cancer patient.
Sandra Nora González-DíazOscar Vidal-GutiérrezJosé Carlos Rodríguez RománRaquel A López HenríquezCarlos Macouzet SánchezCindy E de Lira QuezadaNatalhie Acuña OrtegaPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
An oral provocation test was performed for two days, presenting localized macular lesions eight hours after the administration of abiraterone. An oral desensitization protocol was carried out for ten days in which no hypersensitivity reactions were observed, thus achieving the successful administration of abiraterone.